BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hyperion Therapeutics 

2000 Sierra Point Parkway
Suite 400
San Francisco  California  94005  U.S.A.
Phone: 1-650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


SEARCH JOBS










 Company News
Horizon Pharma (HZNP) Completes Acquisition Of Hyperion Therapeutics (HPTX) 5/7/2015 11:34:23 AM
Horizon Pharma (HZNP) Announces Expiration Of HSR Waiting Period For Proposed Hyperion Therapeutics (HPTX) Acquisition 4/30/2015 11:10:11 AM
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/30/2015 7:40:34 AM
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015 6:44:24 AM
Hyperion Therapeutics (HPTX) To Present At 27th Annual ROTH Conference 3/6/2015 8:03:03 AM
Hyperion Therapeutics (HPTX) Observes Rare Disease Day 2015 2/27/2015 7:57:58 AM
Hyperion Therapeutics (HPTX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015 7:30:24 AM
Hyperion Therapeutics (HPTX) To Present At The Cowen and Company 35th Annual Health Care Conference 2/26/2015 8:20:54 AM
Hyperion Therapeutics (HPTX) To Report Fourth Quarter And Full Year 2014 Financial Results After Market On February 26, 2015 2/20/2015 7:30:39 AM
Hyperion Therapeutics (HPTX) Enters Into Completion Of Phase III Clinical Trial, Option And Mutual Release Agreement With Clal Biotechnology Industries And Yeda Research and Development Company Ltd. 2/17/2015 7:22:49 AM
12345678910...